Mr Matthew Gardiner Clinical Lecturer, University of Oxford Specialist Registrar in Plastic Surgery Mid Essex Hospitals RSTN Representative Miss Charlotte Ives ST8, Breast Surgery Penninsula Deanery Mammary Fold Academic and Research Collaborative Representative Professor Chris Holcombe Professor of Breast Surgery Royal Liverpool Hospital ABS Academic and Research Committee Representative Mr Abhilash Jain Clinical Senior Lecturer in Plastic and Hand Surgery, University of Oxford, Honorary Consultant Plastic Surgeon, Imperial College Healthcare NHS Trust RCS SSL in Plastic and Hand Surgery Mr Baek Kim ST6 Breast trainee Yorkshire and the Humber Deanery Project Originator Mammary Fold Academic and Research Collaborative Representative () Mr R Douglas Macmillan Consultant Oncoplastic Breast Surgeon Nottingham Breast Institute City Hospital Senior Protocol Advisor Mr John Murphy Consultant Oncoplastic Breast Surgeon University Hospital Manchester Senior Protocol Advisor Miss Shelley Potter Academic Clinical Lecturer Centre for Surgical Research University of Bristol Mr Tim Rattay NIHR Doctoral Fellow Department of Cancer StudiesUniversity of Leicester Mr Dennis Remoundos Consultant Oncoplastic Breast Surgeon Oxford Mr Richard Sutton Consultant Oncoplastic Breast Surgeon Royal United Hospital Bath Mr Adam Trickey Research Associate School of Social and Community Medicine, University of Bristol Statistician and methodology Miss Kate Williams National Oncoplastic Fellow President, Mammary Fold University Hospitals South Manchester Methodological Support Bristol Surgical Trials Centre School of Social and Community Medicine University of Bristol On behalf of the Mammary Fold Academic Committee (mfac.research@gmail.com) Website: www.themammaryfold/research-collaboratives-3/
Haematoma - A collection of following the TM procedure Minor – managed conservatively by aspiration in clinic or Major – requiring surgical evacuation. Infection - A hot, red swollen breast associated with one of the following; a temperature, pus at the wound site, a raised white cell count; a positive wound culture within the first 30 days following surgery. This will be further classified as: Minor – requiring oral antibiotics only; Major 1 – requiring admission for IV antibiotics and/or debridement; 2 – requiring surgical drainage/debridement Skin necrosis - any area of skin loss on the operated breast including T junction Minor – managed conservatively with dressings – requiring surgical debridement under general anaesthesia (GA) Wound dehiscence – separation of skin edges at any of the wound sites Minor – treated conservatively; – requiring return to theatre Nipple necrosis – Any area of necrosis of the nipple areolar complex (NAC) Minor – managed conservatively with dressings; 1 – requiring surgical debridement under GA; Major 2 – complete nipple loss In hospital complication – any complication that occurs during the patient’s initial hospital stay at the time of their TM. This includes systematic complications such as DVT/PE and procedure specific complications such as haematoma. Readmission to hospital – any re-admission to hospital in 30 days following surgery directly related to the procedure (e.g with infection requiring antibiotics or systemic complications including pulmonary embolus) Return to theatre – Return to the operating theatre at any time during the first 30 days following surgery to deal with any complication of the TM. Major complication - Any complication requiring readmission to hospital or return to theatre Minor complication - Any other complication